BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 19389436)

  • 1. siRNA vs. shRNA: similarities and differences.
    Rao DD; Vorhies JS; Senzer N; Nemunaitis J
    Adv Drug Deliv Rev; 2009 Jul; 61(9):746-59. PubMed ID: 19389436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative assessment of siRNA and shRNA off target effects: what is slowing clinical development.
    Rao DD; Senzer N; Cleary MA; Nemunaitis J
    Cancer Gene Ther; 2009 Nov; 16(11):807-9. PubMed ID: 19713999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of RNA interference against cancer.
    Takeshita F; Ochiya T
    Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transkingdom RNA interference (tkRNAi) as a new delivery tool for therapeutic RNA.
    Aigner A
    Expert Opin Biol Ther; 2009 Dec; 9(12):1533-42. PubMed ID: 19769540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
    Vorhies JS; Nemunaitis J
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):373-82. PubMed ID: 17338656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for short hairpin RNA delivery in cancer gene therapy.
    Wang SL; Yao HH; Qin ZH
    Expert Opin Biol Ther; 2009 Nov; 9(11):1357-68. PubMed ID: 19761417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatically prepared RNAi libraries.
    Buchholz F; Kittler R; Slabicki M; Theis M
    Nat Methods; 2006 Sep; 3(9):696-700. PubMed ID: 16929314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicogenomics of non-viral drug delivery systems for RNAi: potential impact on siRNA-mediated gene silencing activity and specificity.
    Akhtar S; Benter I
    Adv Drug Deliv Rev; 2007 Mar; 59(2-3):164-82. PubMed ID: 17481774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primer extension-based method for the generation of a siRNA/miRNA expression vector.
    Gou D; Zhang H; Baviskar PS; Liu L
    Physiol Genomics; 2007 Nov; 31(3):554-62. PubMed ID: 17804605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced target gene knockdown by a bifunctional shRNA: a novel approach of RNA interference.
    Rao DD; Maples PB; Senzer N; Kumar P; Wang Z; Pappen BO; Yu Y; Haddock C; Jay C; Phadke AP; Chen S; Kuhn J; Dylewski D; Scott S; Monsma D; Webb C; Tong A; Shanahan D; Nemunaitis J
    Cancer Gene Ther; 2010 Nov; 17(11):780-91. PubMed ID: 20596090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of RNA interference triggers to sensory neurons in vivo using herpes simplex virus.
    Anesti AM; Coffin RS
    Expert Opin Biol Ther; 2010 Jan; 10(1):89-103. PubMed ID: 20420517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of shRNA inhibitors by variation of the terminal loop sequence.
    Schopman NC; Liu YP; Konstantinova P; ter Brake O; Berkhout B
    Antiviral Res; 2010 May; 86(2):204-11. PubMed ID: 20188764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying siRNA-induced off-targets by microarray analysis.
    Anderson E; Boese Q; Khvorova A; Karpilow J
    Methods Mol Biol; 2008; 442():45-63. PubMed ID: 18369777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA interference for studying the molecular basis of neuropsychiatric disorders.
    Hoyer D
    Curr Opin Drug Discov Devel; 2007 Mar; 10(2):122-9. PubMed ID: 17436547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small silencing RNAs: state-of-the-art.
    Grimm D
    Adv Drug Deliv Rev; 2009 Jul; 61(9):672-703. PubMed ID: 19427885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic production of RNAi libraries from cDNAs.
    Shirane D; Sugao K; Namiki S; Tanabe M; Iino M; Hirose K
    Nat Genet; 2004 Feb; 36(2):190-6. PubMed ID: 14704669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of RNA interference techniques to adipose cell cultures.
    Shimba S
    Methods Mol Biol; 2008; 456():249-57. PubMed ID: 18516566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference in mice.
    Kühn R; Streif S; Wurst W
    Handb Exp Pharmacol; 2007; (178):149-76. PubMed ID: 17203655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects of RNA interference therapy for cancer.
    Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC
    Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.